Shares of Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) dropped 8.4% during mid-day trading on Monday . The company traded as low as $3.31 and last traded at $3.37. 205 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 58,836 shares. The stock had previously closed at $3.68.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded Raia Drogasil to a “hold” rating in a research report on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold”.
Get Our Latest Stock Report on RADLY
Raia Drogasil Trading Down 7.9%
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Read More
- Five stocks we like better than Raia Drogasil
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
